T4-binding globulin (TBG) is a glycoprotein synthesized by the liver and is the principal carrier of T4 and T3 in serum. In this report, we demonstrate that the Hep G2 cell line, derived from a human hepatoblastoma, synthesizes and secretes TBG, the properties of which were characterized. Hep G2 cells secreted TBG into the medium after more than 100 transfers in tissue culture conditions. At confluency and after changing to serum-free culture conditions, TBG accumulation into the medium was linear for 3 days and constituted approximately 0.16% of the proteins synthesized over 24 h. Its abundance relative to albumin is 10-fold greater than that found in normal human serum. TBG secreted by the Hep G2 cells was indistinguishable from native normal human serum TBG, as determined immunologically, by electrophoresis on polyacrylamide gel in denaturing and nondenaturing conditions, and by isoelectric focusing. It also specifically bound T4 and T3, albeit with slightly reduced affinity, and had increased heat lability. Although slightly different from normal serum TBG in caucasians, the physical and biological properties of the Hep G2-derived TBG are similar to those of the variant TBG found in the serum of some healthy Australian Aborigines.

Download full-text PDF

Source
http://dx.doi.org/10.1210/jcem-60-3-472DOI Listing

Publication Analysis

Top Keywords

serum tbg
12
tbg
9
hep cells
8
culture conditions
8
normal human
8
human serum
8
serum
5
characterization thyroxine-binding
4
thyroxine-binding globulin
4
globulin secreted
4

Similar Publications

Multi-year enzyme expression in patients with mucopolysaccharidosis type VI after liver-directed gene therapy.

Med

November 2024

Department of Translational Medicine, "Federico II" University, 80131 Naples, Italy; Telethon Institute of Genetics and Medicine, 80078 Pozzuoli, Italy; Scuola Superiore Meridionale (SSM, School of Advanced Studies), Genomics and Experimental Medicine Program, University of Naples Federico II, 80138 Naples, Italy. Electronic address:

Background: Mucopolysaccharidosis type VI (MPS VI) is due to a deficiency of the lysosomal enzyme arylsulfatase B (ARSB) that results in multi-organ accumulation of glycosaminoglycans (GAGs). Limitations of current treatments prompted the development of a liver-directed gene therapy clinical trial for MPS VI.

Methods: We report the long-term follow-up of patients with MPS VI who discontinued enzyme replacement therapy (ERT) and received a single intravenous infusion of high-dose (6 × 10 genome copies/kg) recombinant adeno-associated virus serotype 8 (AAV8) vector expressing ARSB under the control of a liver-specific promoter (ClinicalTrials.

View Article and Find Full Text PDF

Unconjugated bilirubin promotes uric acid restoration by activating hepatic AMPK pathway.

Free Radic Biol Med

November 2024

Department of Pharmacology, School of Basic Medical Sciences, Zhejiang University, Hangzhou, 310058, China; Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Hangzhou First People's Hospital, Hangzhou, 310006, China; Westlake Laboratory of Life Sciences and Biomedicine of Zhejiang Province, Hangzhou, 310024, China. Electronic address:

Article Synopsis
  • Hyperuricemia, a condition leading to gout, is often caused by high activity of xanthine oxidase, which produces uric acid.
  • This study found that lower bilirubin levels are linked to higher uric acid levels in patients with new-onset hyperuricemia and advanced gout.
  • Researchers showed that bilirubin could reduce uric acid levels in mice by enhancing liver function and cellular processes, suggesting it might offer a new approach for managing hyperuricemia in humans.
View Article and Find Full Text PDF

Background & Aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) has become the most prevalent chronic liver disorder, with no approved treatment. Our previous work demonstrated the efficacy of a pan-ErbB inhibitor, Canertinib, in reducing steatosis and fibrosis in a murine fast-food diet (FFD) model of MASLD. The current study explores the effects of hepatocyte-specific ErbB1 (ie, epidermal growth factor receptor [EGFR]) deletion in the FFD model.

View Article and Find Full Text PDF

Per- and poly-fluorinated compounds constitute a wide group of fluorocarbon chemicals with widespread industrial applications, ranging from non-stick coating in cookware to water surfactants, from fire-fighting foams to water-repellent coatings on textiles. Presently, over 12,000 PFAS are known worldwide. In recent years, extensive research has focused on investigating the biological effects of these molecules on various organisms, including humans.

View Article and Find Full Text PDF

Effects of pethoxamid treatment on the disposition of thyroxine in rats.

Toxicol Appl Pharmacol

June 2024

FMC Corporation, 2929 Walnut St, Philadelphia, PA, USA. Electronic address:

Article Synopsis
  • - Pethoxamid (PXA) is a chloroacetamide herbicide that inhibits weed germination and has been found to cause thyroid follicular cell hyperplasia in high-dose male rats, but does not act as a genotoxic agent.
  • - A study assessed the effects of PXA on the disposition of intravenously administered radioactive thyroxine in bile-duct cannulated rats, compared with a positive control (phenobarbital), showing increased liver weights and altered thyroid hormone clearance.
  • - The findings suggest PXA affects thyroid hormone balance through increased T4 elimination in bile due to enzyme induction mechanisms, but these effects are likely not relevant to humans due to species-specific differences in thyroid hormone metabolism.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!